Vicore Pharma Holding AB (publ) (STO:VICO)
Sweden
· Delayed Price · Currency is SEK 10.02
-0.08 (-0.79%)
Apr 28, 2026, 5:29 PM CET
Vicore Pharma Holding AB Revenue
In the year 2025, Vicore Pharma Holding AB had annual revenue of 3.82M SEK, down -96.51%. Vicore Pharma Holding AB had revenue of 419.00K in the quarter ending December 31, 2025, a decrease of -91.79%.
Revenue
3.82M
Revenue Growth
-96.51%
P/S Ratio
739.03
Revenue / Employee
103.16K
Employees
36
Market Cap
2.82B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Hansa Biopharma AB | 190.49M |
| Egetis Therapeutics AB | 62.40M |
| Flerie AB | 1.80M |
| Saniona AB | 434.40M |
| BioInvent International AB | 226.50M |
| Genovis AB (publ.) | 129.65M |
| Xspray Pharma AB | 2.47M |
| Medivir AB | 8.51M |
Vicore Pharma Holding AB News
- 7 weeks ago - Vicore Pharma Holding AB Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Vicore Pharma Holding AB at TD Cowen Healthcare Conference Transcript - GuruFocus
- 7 weeks ago - Vicore Pharma Holding AB Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Vicore Pharma Holding AB Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference - Transcripts
- 3 months ago - Vicore Pharma Holding AB Transcript: 44th Annual J.P. Morgan Healthcare Conference - Transcripts
- 5 months ago - Vicore Pharma Holding AB Transcript: Jefferies London Healthcare Conference 2025 - Transcripts
- 6 months ago - Vicore Pharma Holding AB Transcript: Stifel 2025 Healthcare Conference - Transcripts
- 6 months ago - Vicore Pharma Holding AB Transcript: Guggenheim Securities 2nd Annual Healthcare Innovation Conference - Transcripts